Skip to main content

Table 3 Analysis of the primary outcome of continuous abstinence at 12 months

From: Effectiveness of a pharmacist-delivered smoking cessation program in the State of Qatar: a randomized controlled trial

  Self-reported 12 months abstinence at the final visit   Continuous abstinence at 12 months (using all data from 3 visits)  
  OR (95% confidence interval) p-value OR (95% confidence interval) p-value
Unadjusted OR 1.54 (0.73, 3.29) 0.259 1.58 (0.53, 4.70) 0.414
Adjusted ORa 1.54 (0.80, 2.99) 0.196 1.58 (0.45, 5.58) 0.480
Adjusted ORb 1.62 (0.65, 4.04) 0.297 1.86 (0.49, 7.07) 0.364
Adjusted ORc 1.60 (0.65, 3.87) 0.306 1.60 (0.43, 5.90) 0.483
Adjusted ORd 1.37 (0.67, 2.80) 0.393 1.34 (0.47, 3.85) 0.589
  1. aadjusted for clustering effect within pharmacists badjusted for years of smoking, cigarettes per day, tried quitting before, diabetes and nationality cadjusted for the number of monitoring visits the participants attended dall those lost to follow up were considered as smokers